| Description: |
The quinoxaline-1,4-dioxide compound carbadox is used in pigs as a growth-promoting agent for the improvement of weight gain and feed efficiency. It is also administered as an antibacterial drug against dysentry and bacterial enteritis in pigs. Following oral administration it metabolises to the compound Quinoxaline Carboxylic Acid (QCA) (3). Maximum residue levels were established for 30 ppb in liver and 5 ppb in muscle however it was concluded that use of carbadox according to good practice in veterinary medicine does not represent a dietary hazard to human health.
|
| DilnFactor:
|
40
|
| Format:
|
The conjugate is supplied as a concentrate. Dilute as required and use working strength conjugate immediately after dilution
|
| Lot:
|
ESC1750
|
| Specificity:
|
Each conjugate comprises antigen covalently bound to horseradish peroxide and is suitable as a tracer in immunoassay development.
|
| Storage:
|
+2-+8C for up to 3 months / <20C for long term storage
|
| References:
|
3. Heird, C.E. (2002/2003) Concentration and depletion of carbadox, deoxycarbadox and quinoxaline-2-carboxylic acid (QCA) in tissue and rendered material of growing swine after consumption of carbadox at 50 g/ton of feed. Unpublished report from Southwest Bio-Labs, Inc. Submitted to WHO by Phibro Animal Health, Fairfield, New Jersey, USA.
|
